Reliant Glycosciences

Reliant Glycosciences

Biotechnology, 400 Riverhill Business Park, Birmingham, Alabama, 35242, United States, 1-10 Employees

reliantglycosciences.com

  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is RELIANT GLYCOSCIENCES

Reliant Glycosciences, LLC is a biotechnology company that focuses on developing diagnostic and prognostic tools for patients with IgA nephropathy. IgA nephropathy is a common kidney dise...

Read More

map
  • 400 Riverhill Business Park, Birmingham, Alabama, 35242, United States Headquarters: 400 Riverhill Business Park, Birmingham, Alabama, 35242, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from RELIANT GLYCOSCIENCES

Reliant Glycosciences Org Chart and Mapping

Employees

Tomasz Szul

Assay Development Scientist

Tomasz Szul

Product Manager/Assay Development Scientist

Tatum Street

Communications Manager

Tatum Street

Communications Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Reliant Glycosciences

Answer: Reliant Glycosciences's headquarters are located at 400 Riverhill Business Park, Birmingham, Alabama, 35242, United States

Answer: Reliant Glycosciences's phone number is +12*********

Answer: Reliant Glycosciences's official website is https://reliantglycosciences.com

Answer: Reliant Glycosciences's revenue is Under $1 Million

Answer: Reliant Glycosciences has 1-10 employees

Answer: Reliant Glycosciences is in Biotechnology

Answer: Reliant Glycosciences contact info: Phone number: +12********* Website: https://reliantglycosciences.com

Answer: Reliant Glycosciences, LLC is a biotechnology company that focuses on developing diagnostic and prognostic tools for patients with IgA nephropathy. IgA nephropathy is a common kidney disease affecting more than 150,000 Americans. Reliant was spun-out in 2016 from UAB. The Reliant founders formed to address the unmet need and demand for disease-specific biomarkers to aid in development of disease specific therapies. Reliants goal is to develop marketable assays for these IgAN-specific biomarkers so that they can be available to the IgAN research community as well as pharmaceutical companies interested in developing treatments for IgAN. Reliant's goal is to have an impact on the disease itself and it's treatment.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access